Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns
Open Access
- 11 June 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 2, 26
Abstract
Blood transfusions are routinely done in every medical regimen and a world wide established collection, processing/storage centers provide their services for the same. There have been extreme global demands for both raising the current collections and supply of safe/adequate blood due to increasingly demanding population. Since, various risks remain associated with the donor derived blood, and a number of post collection blood screening and processing methods put extreme constraints on supply system especially in the underdeveloped countries. A logistic approach to manufacture erythrocytes ex-vivo by using modern tissue culture techniques have surfaced in past few years. There are several reports showing possibilities of RBCs (and even platelets/ neutrophils) expansion under tightly regulated conditions. In fact, ex vivo synthesis of few units of clinical grade RBCs from a single dose of starting material such as umbilical cord blood has been well established. Similarly, many different sources are also being explored for the same purpose such as embryonic stem cells, induced pluripotent stem cells. However, the major concerns remain elusive before the manufacture and clinical use of different blood components may be used to successfully replace the present system of donor derived blood transfusion. Most important factor shall include the large scale of RBCs production from each donation unit within a limited time period and cost of their production both of these issues need to be handled carefully since many of the recipients among developing countries are unable to pay even for the freely available donor derived blood. Anyways, keeping these issue in mind, present article shall be focused on the feasibilities of blood production and their use in near future.Keywords
This publication has 140 references indexed in Scilit:
- Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signaturesCell Research, 2011
- From stem cell to erythroblast: Regulation of red cell production at multiple levels by multiple hormonesIUBMB Life, 2010
- Prolonged continuous in vitro human platelet production using three-dimensional scaffoldsExperimental Hematology, 2009
- Diverse hematopoietic potentials of five human embryonic stem cell linesExperimental Cell Research, 2008
- Chapter 2 The Erythroblastic Island2008
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998